Study of BZ371A for women with sexual arousal disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 21 and 60 years old.
- You have been diagnosed with Female Sexual Arousal Disorder (FSAD), meaning you often struggle to get or maintain physical arousal during sex.
- You have been in a stable relationship with a sexually active partner for at least 6 months.
- You agree to try having sex at least twice a week while taking the study medication.
- You are willing to use birth control if you could become pregnant, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication (BZ371A) that may help women with sexual arousal disorder—a condition where the body doesn't respond physically (like lubrication or swelling) despite feeling interested. The trial aims to see if this medication can increase sexual arousal, and checks safety and side effects over a period of time with your partner.
This study tests a device that uses gentle electrical stimulation to improve sexual function in women. You can use it at home after being trained at the study center.
This study tests an experimental medication (S1B-408) to see if it helps women who have trouble reaching orgasm. The trial will check if the drug improves orgasm function compared to a placebo, and you will need to have a willing partner and be sexually active.
This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.
This study tests an experimental vaginal cream (AZU-101) for postmenopausal women who have vaginal dryness and pain during sex. The goal is to see if it can improve these symptoms without the risks of hormone treatments.
This study tests health and wellness products to see if they improve sexual health and related outcomes in women. Participants will take a product (either the active one or a placebo) for 12 weeks and track their experiences.
Hear when a new Female Sexual Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.